# OnCo record fast-track-rmat (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/fast-track-rmat/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "fast-track-rmat" ;
  schema:name "Fast Track and RMAT designations"@en ;
  schema:alternateName "Fast Track"@en, "fast-track designation"@en, "Fast Track designation"@en, "RMAT"@en, "regenerative medicine advanced therapy"@en, "RMAT designation"@en, "PRIME"@en, "PRIority MEdicines"@en, "expedited programme"@en, "expedited program"@en, "expedited pathway"@en, "expedited review"@en, "expedited approval"@en, "fast track designations"@en ;
  schema:description "Two of the FDA's expedited programmes: Fast Track gives drugs for serious unmet needs more frequent FDA meetings and rolling review; RMAT is the equivalent for cell and gene therapies. Neither guarantees approval or changes the evidence standard."@en ;
  schema:url <https://onco.cc/terms/fast-track-rmat/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fast_track_(FDA)> ;
  schema:citation <https://en.wikipedia.org/wiki/Fast_track_(FDA)> ;
  onco:related <https://onco.cc/terms/breakthrough-designation/>, <https://onco.cc/terms/accelerated-approval/>, <https://onco.cc/terms/orphan-designation/>, <https://onco.cc/terms/bla-nda/>, <https://onco.cc/terms/fdasia-2012/>, <https://onco.cc/terms/21st-century-cures-act/>, <https://onco.cc/terms/sakigake/>, <https://onco.cc/terms/ilap/>, <https://onco.cc/terms/eu-regulation-726-2004/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> .
